Q3 2024 Earnings Estimate for Sarepta Therapeutics, Inc. Issued By Zacks Research (NASDAQ:SRPT)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Equities research analysts at Zacks Research boosted their Q3 2024 earnings per share estimates for shares of Sarepta Therapeutics in a research note issued on Thursday, January 11th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will earn $0.29 per share for the quarter, […]
More Stories
Health Officials Report More Cases of Flesh-Eating Beach Bacteria
By Jack Phillips Health officials have reported that cases of a rare type of flesh-eating bacteria found in warm seawater...
30-Year Treasury Yield Hits Highest Level in 19 Years
By Naveen Athrappully The U.S. 30-year Treasury yield is trading at levels last seen 19 years ago, near the onset...
No Peace Talks Taking Place With Iran, Trump Says
By Timothy Frudd President Donald Trump said on Aug. 18 that the United States was not holding negotiations with Iran...
Ukraine Launches 620 Drones at Moscow Region, as Russian Missile Attack Kills 10 in Ukraine
By Victoria Friedman Moscow and Kyiv have continued their aerial bombardments of each other, with Ukraine launching hundreds of unmanned...
What is the Entry-Level CCNA Salary? Registration Process, Tracking, and Job Roles
Confused about choosing CCNA as your profession? Curious to know about CCNA salary based on your experience and certifications? Don’t...
Why Businesses Choose Virtual Offices in NYC
Manhattan is one of the most expensive real estate markets in the world, and yet thousands of companies plant their...